Consent as Conversation: Rethinking Informed Consent in Hospice

The daughter signed every page. She nodded when I explained comfort care. But later, when we adjusted her mother’s cholesterol medicine, she said, “Why are we stopping a heart medication? I thought hospice was supposed to help her live comfortably.”

She had signed, but she had not understood. Did I get a signature, or did I build understanding?

In hospice, a signed election records the choice of hospice care. It does not finish the conversation. Understanding must be renewed as illness, choices, and emotions change.

Three processes often overlap in hospice:

The patient or representative signs the hospice election.

Physicians certify terminal-illness eligibility.

The patient or surrogate makes ongoing decisions about treatments and the plan of care.

They are related, but not interchangeable (42 C.F.R. §§ 418.22, 418.24, 418.52). Informed consent is decision-specific and should be revisited when choices or circumstances change.

For each decision, explain the reasonable options, expected benefits, burdens, and risks, including the choice to decline. Then ask the patient or surrogate to explain the plan in their own words (American Medical Association, n.d.-b).

Every encounter, including a medication change or family meeting, can reveal whether understanding still holds.

Hospice Synopsis frames this as the Consent Loop: Ask → Explain → Teach Back → Document → Revisit Use it when a decision changes or understanding is uncertain.

Meaning can fade, even in the best circumstances.

In a selected sample of 110 hospice patients without documented or obvious cognitive impairment, 54% had significant previously undetected cognitive impairment (Burton et al., 2012). That finding is a warning to check understanding, not a reason to presume incapacity. Capacity is specific to the decision and may change over time.

When concern arises, assess the patient’s ability to understand, appreciate, reason, and communicate a choice. Involve the patient as much as possible. If the patient lacks capacity for that decision, identify the appropriate surrogate under applicable law and policy. Use substituted judgment when the patient’s wishes are known and the best-interest standard when they are not (American Medical Association, n.d.-a; American Psychiatric Association, 2019).

Use plain language with everyone. Use a qualified interpreter when needed. Ask the patient or surrogate to explain the decision in their own words. If the answer shows a gap, explain again and recheck (Agency for Healthcare Research and Quality, 2020, 2024).

Every informed-consent conversation follows a rhythm. These steps are anchors, not checklists. They free us to listen with focus and integrity.

Name the decision. “Today we are deciding whether hospice fits your goals.”

Explain the choices. Describe reasonable alternatives, including the choice to decline.

Explain expected benefits, burdens, risks, and limits. For a Medicare hospice election, include what the benefit covers, the services for which Medicare payment is waived, and the palliative rather than curative nature of hospice care for the terminal illness and related conditions. Clarify that 24/7 availability does not mean continuous bedside presence.

Invite values and questions. “What matters most to you, and what worries you?”

Confirm understanding. “Please tell me in your own words what you understand and what you are choosing.”

Document who participated, what was explained, the response to teach-back, and the decision.

(42 C.F.R. § 418.24; Agency for Healthcare Research and Quality, 2020; American Medical Association, n.d.-b)

This is how teach-back changes a signature into understanding. During one admission, a nurse paused when a daughter hesitated after signing. She asked, “Can you tell me in your own words what hospice means for your mom?” The daughter replied, “It means you’ll keep her comfortable, not stop caring.” Later she told the team, “Once I could explain it to my brother, I finally believed it myself.”

Even clear words can miss their mark. Slow down and recheck understanding when:

cognition, attention, or communication changes;

fear or distress limits participation;

the patient or family uses a different language;

the decision is complex, high stakes, or disputed; or

the patient or surrogate cannot explain the decision in their own words.

Use a qualified interpreter when needed. Do not infer incapacity from age, diagnosis, disability, disagreement, or limited English proficiency. The less someone has heard about hospice before today, the more time the conversation deserves.

Medication changes can feel like loss. Explain why a change is being considered, the reasonable alternatives, expected benefits and burdens, and what to watch for. Ask which medicines still feel important and why. Reassure the patient and family that the team is tailoring care, not withdrawing it. Document the decision and follow-up plan.

Deprescribing is informed consent in action.

Consent protects both autonomy and trust. The patient or representative signs the hospice election. Physicians separately certify terminal-illness eligibility. Neither signature replaces informed consent for later treatment decisions.

For a treatment decision, explain reasonable options, benefits, burdens, and risks in plain language. Reassess capacity when the decision or the patient’s condition raises concern, not merely because recertification is due. When a surrogate decides, explain that the role is to represent the patient’s known wishes or best interests.

Use teach-back for important decisions and document the response.

Reassess capacity when a decision-specific concern arises.

Bring unresolved questions about understanding, capacity, or disagreement to the IDG and, when needed, the appropriate ethics or legal resource.

Train staff to distinguish election, certification, and informed consent.

Consent doesn’t erase risk; it makes meaning visible and shareable.

AHRQ and the AMA describe informed consent as a communication process, not a signature alone. Their guidance supports plain language, meaningful choices, teach-back, and documentation. Serious-illness communication guidance supports repeated conversations as patients integrate prognosis and goals over time (Agency for Healthcare Research and Quality, 2020, 2024; American Medical Association, n.d.-b; Jackson & Emanuel, 2024).

For quality improvement, teams can track whether patients or surrogates can explain the current decision, whether questions remain, and whether the discussion and decision are documented.

In hospice, consent is more than paperwork. It is a relationship renewed each time we explain, listen, and confirm.

Understanding can settle some of the anxiety around comfort-focused care. A patient once whispered, “Now I understand. Comfort isn’t giving up. It’s letting go with peace.”

True consent honors both comprehension and trust. Did I get a signature, or did I build understanding?

A signature should record a decision, not substitute for the conversation.